Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Lodo Therapeutics

Lodo Therapeutics
2015 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$19.9M LATEST DEAL AMOUNT
14 INVESTORS
Description

Operator of a drug discovery and development company designed to focus on the creation of novel therapeutics derived from nature. The company's therapeutic drugs are produced from bioactive natural products directly from the microbial DNA sequence information contained in soil, enabling healthcare providers to treat drug-resistant microbial infections and cancers.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Primary Office
  • 1616 Eastlake Avenue East
  • Suite 200
  • Seattle, WA 98102
  • United States

+1 (206) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Lodo Therapeutics’s full profile, request a free trial.

Lodo Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 18-Jan-2016 $19.9M 000.00 0000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Lodo Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 00,000,000 00.000000 00 00 00 00 00.000
To view this company’s complete Cap Table, request access »

Lodo Therapeutics Competitors (25)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Visterra Formerly VC-backed Waltham, MA 00 00000 000000&0 00000
0000000 0000000000 Formerly VC-backed Heidelberg, Germany 000 00000 00000000000 00000
00000 000000000000 Formerly VC-backed Palatine, IL 00 00000 000000000 00000
0000000 0000000000 Formerly VC-backed Watertown, MA 00 00000 000000000 00000
000000 00000000000 Failed Transaction (M&A) Cambridge, MA 000 00000 000000&0
To view this company’s complete list of competitors, request access »

Lodo Therapeutics Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
180 Degree Capital Venture Capital Minority 000 0000 000000 0
AbbVie Ventures Corporate Venture Capital Minority 000 0000 000000 0
Accelerator Life Science Partners Venture Capital Minority 000 0000 000000 0
Alexandria Venture Investments Corporate Venture Capital Minority 000 0000 000000 0
ARCH Venture Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »

Lodo Therapeutics Executive Team (3)

Name Title Board
Seat
Contact
Info
David Pompliano Ph.D Chief Scientific Officer & Co-Founder
Sean Brady Ph.D Co-Founder
Thong Le Chief Executive Officer & Board Member

Lodo Therapeutics Board Members (6)

Name Representing Role Since Contact
Info
Asish Xavier Lodo Therapeutics Board Member 000 0000
James Sullivan Lodo Therapeutics Board Member 000 0000
Joel Marcus Lodo Therapeutics Board Member 000 0000
Johnston Erwin Lodo Therapeutics Board Member 000 0000
Misti Ushio Lodo Therapeutics Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »